Chemomab

Chemomab Therapeutics – Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases

Total Funding
$20.0M
Last Round
$10.0M Private EquityJul 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Chemomab Therapeutics is a clinical-stage biotechnology company developing therapeutics for fibro-inflammatory diseases with high unmet need, such as primary sclerosing cholangitis and liver, skin, and lung fibrosis. The company discovered that the soluble protein CCL24 drives the fibro-inflammatory cycle underlying these conditions, and its lead candidate, nebokitug (CM-101), is designed to bind to and neutralize CCL24. Nebokitug has generated positive results across five clinical trials, including 15-week and 48-week data from the Phase 2 SPRING trial in primary sclerosing cholangitis patients.

Summary

Chemomab is a Biotech company. It has raised $20.0M in total across 2 rounds, most recently a $10.0M Private Equity round in Jul 2024. Investors include HBM Healthcare Investments and OrbiMed.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityJul 2024
$10.0M

Sign up to see all 3 events

Funding: Series B through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Chemomab on Indexed.vc
<a href="https://indexed.vc/companies/chemomab"><img src="https://indexed.vc/api/badge/company/chemomab" alt="Chemomab on Indexed.vc" width="260" height="76" /></a>